Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids
- PMID: 18182067
- PMCID: PMC2730932
- DOI: 10.1111/j.1582-4934.2007.00207.x
Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids
Retraction in
-
Retracted: Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.J Cell Mol Med. 2015 Oct;19(10):2512. doi: 10.1111/jcmm.12621. J Cell Mol Med. 2015. PMID: 26411639 Free PMC article.
Abstract
Given the emerging roles of microRNAs (miRNAs) as key regulator of mRNA stability we assessed their expression profile in paired myometrium and leiomyoma, their isolated smooth muscle cells (MSMC and LSMC), a spontaneously transformed leiomyoma smooth muscle cells (T-LSMC) and SK-LMS-1, a leiomyosarcoma cell line using microarray and real time PCR. Based on global normalization of expression values of 385 miRNAs and statistical analysis (anova), 91 miRNAs were expressed above the threshold levels in myometrium, with a progressive decline in numbers in leiomyomas, MSMC, LSMC, T-LSMC and SK-LMS-1 (P<0.05). We selected and validated the expression of miR-20a, miR-21, miR-26a, miR-18a, miR-206, miR-181a and miR-142-5p and found their differential expression in tissue and cell-specific manners (P<0.05). Treatments of MSMC and LSMC with 17beta estradiol and medroxyprogesterone acetate (10(-8)M), or ICI-182780 and RU-486 (10(-6)M) resulted in differential regulation of these miRNAs (P<0.05). In conclusion, the expression of a number of miRNAs in myometrium and leiomyoma with their progressive aberrant from normal MSMC into LSMC, transformed and cancerous stage, suggests that miRNAs and their regulation by ovarian steroids play a key role in pathogenesis of leiomyoma through gene expression stability.
Figures
Comment in
-
Findings of Research Misconduct.Fed Regist. 2017 Aug 3;82(148):36150-36151. Fed Regist. 2017. PMID: 28857091 Free PMC article. No abstract available.
References
-
- Varol N, Healey M, Tang P, Sheehan P, Maher P, Hill D. Ten-year review of hysterectomy morbidity and mortality: Can we change direction? Aust N Z J Obstet Gynaecol. 2001;41:295–302. - PubMed
-
- Al Hendy A, Salama SA. Catechol-o-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13:136–44. - PubMed
-
- Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, Tong D. Genotype distribution of estrogen receptor-alpha, catechol-o-methyl-transferase, and cytochrome P450 17 gene polymorphisms in caucasian women with uterine leiomy-omas. Fertil Steril. 2006;85:462–7. - PubMed
-
- Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, Girao MJ, Nishimura E, Baracat EC, Silva ID. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids. 2006;71:960–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
